Home > Boards > US Listed > Medical - Drugs > Oramed Pharmaceuticals (ORMP)

I am surprised that it is holding up

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Spicknspan Member Profile
 
Followed By 23
Posts 1,252
Boards Moderated 0
Alias Born 11/23/12
160x600 placeholder
Oramed Elects Dr. Alexander Fleming to Scientific Advisory Board PR Newswire (US) - 1/23/2020 8:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/21/2020 2:41:09 PM
Oramed Appoints Dr. Jay Skyler to Scientific Advisory Board PR Newswire (US) - 1/21/2020 7:25:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 1/9/2020 3:58:01 PM
Oramed Pharmaceuticals Issues Letter to Shareholders PR Newswire (US) - 1/9/2020 7:00:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/11/2019 4:53:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/6/2019 6:02:01 AM
Oramed Appoints Dr. Arie Mayer to Board of Directors PR Newswire (US) - 12/5/2019 9:12:00 AM
Oramed to Present a Scientific Poster at International Diabetes Federation Congress PR Newswire (US) - 12/2/2019 8:25:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 11/27/2019 4:28:28 PM
Oramed Patent Granted in Japan for Protease Inhibitor, a Key Component of Platform Technology PR Newswire (US) - 11/21/2019 8:27:00 AM
Oramed Provides Highlights and Data From Its Phase IIb Oral Insulin Study Investor Event PR Newswire (US) - 11/19/2019 8:55:00 AM
Oramed Pharmaceuticals to Discuss Positive Phase IIb Data at Investor Event and Conference Call on Monday, November 18th PR Newswire (US) - 11/14/2019 7:28:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2019 7:04:56 AM
Oramed Announces Successful Phase IIb Study of Oral Insulin in Type 2 Diabetes PR Newswire (US) - 11/12/2019 7:00:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 10/23/2019 4:36:39 PM
Oramed to Present at Ladenburg Thalmann 2019 Healthcare Conference PR Newswire (US) - 9/18/2019 8:38:00 AM
Oramed Announces Last Patient Treated in Pivotal Phase IIb Trial of Oral Insulin ORMD-0801 PR Newswire (US) - 9/17/2019 8:40:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2019 6:09:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2019 6:08:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2019 6:07:48 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/16/2019 6:07:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2019 6:07:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2019 6:06:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/11/2019 5:18:02 PM
Spicknspan   Saturday, 10/07/17 10:31:24 AM
Re: Lynx7 post# 499
Post # of 525 
I am surprised that it is holding up so well. It could break out to the upside.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist